Influence of immune activation and inflammatory response on cardiovascular risk associated with the human immunodeficiency virus

References

• PalellaFJDelaneyKMMoormanACDeclining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study InvestigatorsN Engl J Med1998338138538609516219
   PubMed Web of Science ®Google Scholar
• MocroftALedergerberBKatlamaCEuroSIDA study groupDecline in the AIDS and death rates in the EuroSIDA study: an observational studyLancet20033629377222912853195
   PubMed Web of Science ®Google Scholar
• LimaVDHoggRSHarriganPRContinued improvement in survival among HIV-infected individuals with newer forms of highly active antiretroviral therapyAIDS200721668569217413689
   PubMed Web of Science ®Google Scholar
• LuzPMBruyandMRibeiroSIPEC/FIOCRUZ Cohort and the Aquitaine ANRS C03 Study GroupAIDS and non-AIDS severe morbidity associated with hospitalizations among HIV-infected patients in two regions with universal access to care and antiretroviral therapy, France and Brazil, 2000–2008: hospital-based cohort studiesBMC Infect Dis20141427824885790
   PubMed Web of Science ®Google Scholar
• PalellaFJJrBakerRKMoormanACHIV Outpatient Study InvestigatorsMortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient studyJ Acquir Immune Defic Syndr2006431273416878047
   PubMed Web of Science ®Google Scholar
• CrumNFRiffenburghRHWegnerSTriservice AIDS Clinical ConsortiumComparisons of causes of death and mortality rates among HIV-infected persons: analysis of the pre-, early, and late HAART (highly active antiretroviral therapy) erasJ Acquir Immune Defic Syndr200641219420016394852
   PubMed Web of Science ®Google Scholar
• MorlatPRoussillonCHenardSANRS EN20 Mortalité 2010 Study GroupCauses of death among HIV-infected patients in France in 2010 (national survey): trends since 2000AIDS20142881181119124901259
   PubMed Web of Science ®Google Scholar
• FrenchALGawelSHHershowRTrends in mortality and causes of death among women with HIV in the United States: a 10-year studyJ Acquir Immune Defic Syndr200951439940619487953
   PubMed Web of Science ®Google Scholar
• MocroftAReissPGasiorowskiJEuroSIDA Study GroupSerious fatal and nonfatal non-AIDS-defining illnesses in EuropeJ Acquir Immune Defic Syndr201055226227020700060
   PubMed Web of Science ®Google Scholar
• BerrySAFleishmanJAMooreRDGeboKAHIV ResearchNetworkTrends in reasons for hospitalization in a multisite United States cohort of persons living with HIV, 2001–2008J Acquir Immune Defic Syndr201259436837522240460
   PubMed Web of Science ®Google Scholar
• EngsigFNHansenABGerstoftJKronborgGLarsenCSObelNInpatient admissions and outpatient visits in persons with and without HIV infection in Denmark, 1995–2007AIDS201024345746119786845
   PubMed Web of Science ®Google Scholar
• CurrierJSLundgrenJDCarrAWorking Group 2Epidemiological evidence for cardiovascular disease in HIV-infected patients and relationship to highly active antiretroviral therapyCirculation20081182e29e3518566319
   PubMedGoogle Scholar
• TriantVALeeHHadiganCGrinspoonSKIncreased acute myo-cardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus diseaseJ Clin Endocrinol Metab20079272506251217456578
   PubMed Web of Science ®Google Scholar
• IslamFMWuJJanssonJWilsonDPRelative risk of cardiovascular disease among people living with HIV: a systematic review and meta-analysisHIV Med201213845346822413967
   PubMed Web of Science ®Google Scholar
• CurrierJSTaylorABoydFCoronary heart disease in HIV-infected individualsJ Acquir Immune Defic Syndr200333450651212869840
   PubMed Web of Science ®Google Scholar
• PalaciosRAlonsoIHidalgoAPeripheral arterial disease in HIV patients older than 50 years of ageAIDS Res Hum Retroviruses20082481043104618620492
   PubMed Web of Science ®Google Scholar
• LorenzMWStephanCHarmjanzABoth long-term HIV infection and highly active antiretroviral therapy are independent risk factors for early carotid atherosclerosisAtherosclerosis2008196272072617275008
   PubMed Web of Science ®Google Scholar
• KingsleyLACuervo-RojasJMuñozASubclinical coronary atherosclerosis, HIV infection and antiretroviral therapy: Multicenter AIDS Cohort StudyAIDS200822131589159918670218
   PubMed Web of Science ®Google Scholar
• PeriardDCavassiniMTafféPSwiss HIV Cohort StudyHigh prevalence of peripheral arterial disease in HIV-infected personsClin Infect Dis200846576176718230043
   PubMed Web of Science ®Google Scholar
• CarrAGrundBNeuhausJSMART Study InvestigatorsAsymptomatic myocardial ischaemia in HIV-infected adultsAIDS200822225726718097228
   PubMed Web of Science ®Google Scholar
• SolagesAVitaJAThorntonDJEndothelial function in HIV-infected personsClin Infect Dis20064291325133216586393
   PubMed Web of Science ®Google Scholar
• SenSRabinsteinAAElkindMSPowersWJRecent developments regarding human immunodeficiency virus infection and strokeCerebrovasc Dis201233320921822261608
   PubMed Web of Science ®Google Scholar
• OvbiageleBNathAIncreasing incidence of ischemic stroke in patients with HIV infectionNeurology201176544445021248273
   PubMed Web of Science ®Google Scholar
• De CastroSd’AmatiGGalloPFrequency of development of acute global left ventricular dysfunction in human immunodeficiency virus infectionJ Am Coll Cardiol1994244101810247930192
   PubMed Web of Science ®Google Scholar
• HollowayCJNtusiNSuttieJComprehensive cardiac magnetic resonance imaging and spectroscopy reveal a high burden of myocardial disease in HIV patientsCirculation2013128881482223817574
   PubMed Web of Science ®Google Scholar
• VallecilloGMojalSRoquerARisk of QTc prolongation in a cohort of opioid-dependent HIV-infected patients on methadone maintenance therapyClin Infect Dis20135781189119423899678
   PubMed Web of Science ®Google Scholar
• MoyersBSSecemskyEAVittinghoffEEffect of left ventricular dysfunction and viral load on risk of sudden cardiac death in patients with human immunodeficiency virusAm J Cardiol201411371260126524521717
   PubMed Web of Science ®Google Scholar
• HasseBLedergerberBFurrerHSwiss HIV Cohort StudyMorbidity and aging in HIV-infected persons: the Swiss HIV cohort studyClin Infect Dis201153111130113921998280
   PubMed Web of Science ®Google Scholar
• DeeksSGPhillipsANHIV infection, antiretroviral treatment, ageing, and non-AIDS related morbidityBMJ2009338a317219171560
   PubMed Web of Science ®Google Scholar
• DeeksSGHIV infection, inflammation, immunosenescence, and agingAnnu Rev Med20116214115521090961
   PubMed Web of Science ®Google Scholar
• EffrosRBFletcherCVGeboKAging and infectious diseases: workshop on HIV infection and aging: what is known and future research directionsClin Infect Dis200847454255318627268
   PubMed Web of Science ®Google Scholar
• GuaraldiGOrlandoGZonaSPremature age-related comorbidities among HIV-infected persons compared with the general populationClin Infect Dis201153111120112621998278
   PubMed Web of Science ®Google Scholar
• KirkJBGoetzMBHuman immunodeficiency virus in an aging population, a complication of successJ Am Geriatr Soc200957112129213819793157
   PubMed Web of Science ®Google Scholar
• DeeksSGPhillipsANHIV infection, antiretroviral treatment, ageing, and non-AIDS related morbidityBMJ2009338a317219171560
   PubMed Web of Science ®Google Scholar
• GouletJLFultzSLRimlandDAging and infectious diseases: do patterns of comorbidity vary by HIV status, age, and HIV severity?Clin Infect Dis200745121593160118190322
   PubMed Web of Science ®Google Scholar
• HenryKMelroeHHuebschJSevere premature coronary artery disease with protease inhibitorsLancet1998351911213289643798
   PubMed Web of Science ®Google Scholar
• GalletBPulikMGenetPChedinPHiltgenMVascular complications associated with use of HIV protease inhibitorsLancet19983519120195819599654285
   PubMedGoogle Scholar
• Friis-MøllerNSabinCAWeberRData Collection on Adverse Events of Anti-HIV Drugs (DAD) Study GroupCombination antiretroviral therapy and the risk of myocardial infarctionN Engl J Med2003349211993200314627784
   PubMed Web of Science ®Google Scholar
• HadiganCMeigsJBCorcoranCMetabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophyClin Infect Dis200132113013911118392
   PubMed Web of Science ®Google Scholar
• HemkensLGBucherHCHIV infection and cardiovascular diseaseEur Heart J201435211373138124408888
   PubMed Web of Science ®Google Scholar
• LazzarettiRKKuhmmerRSprinzEPolanczykCARibeiroJPDietary intervention prevents dyslipidemia associated with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected individuals: a randomized trialJ Am Coll Cardiol2012591197998822402068
   PubMed Web of Science ®Google Scholar
• ConklinBFuWLinPLundsenAYaoQChenCHIV protease inhibitor ritonavir induces endothelial dysfunction in porcine arteriesJ Surg Res2003114249
   Google Scholar
• ShankarSSDubéMPGorskiJCKlaunigJESteinbergHOIndinavir impairs endothelial function in healthy HIV-negative menAm Heart J2005150593316290967
   PubMed Web of Science ®Google Scholar
• LagathuCEustaceBProtMSome HIV antiretrovirals increase oxidative stress and alter chemokine, cytokine or adiponectin production in human adipocytes and macrophagesAntivir Ther200712448950017668557
   PubMed Web of Science ®Google Scholar
• LefèvreCAuclairMBoccaraFPremature senescence of vascular cells is induced by HIV protease inhibitors: implication of prelamin A and reversion by statinArterioscler Thromb Vasc Biol201030122611262020884875
   PubMed Web of Science ®Google Scholar
• El-SadrWMLundgrenJNeatonJDStrategies for Management of Antiretroviral Therapy (SMART) Study GroupCD4+ count-guided interruption of antiretroviral treatmentN Engl J Med2006355222283229617135583
   PubMed Web of Science ®Google Scholar
• FisherSDMillerTLLipshultzSEImpact of HIV and highly active anti-retroviral therapy on leukocyte adhesion molecules, arterial inflammation, dyslipidemia, and atherosclerosisAtherosclerosis2006185111116297390
   PubMed Web of Science ®Google Scholar
• MuHChaiHLinPHYaoQChenCCurrent update on HIV-associated vascular disease and endothelial dysfunctionWorld J Surg200731463264317372667
   PubMed Web of Science ®Google Scholar
• EugeninEAMorgelloSKlotmanMEHuman immunodeficiency virus (HIV) infects human arterial smooth muscle cells in vivo and in vitro: implications for the pathogenesis of HIV-mediated vascular diseaseAm J Pathol200817241100111118310503
   PubMed Web of Science ®Google Scholar
• OshimaTFloresSCVaitaitisGHIV-1 Tat increases endothelial solute permeability through tyrosine kinase and mitogen-activated protein kinase-dependent pathwaysAIDS200014547548210780709
   PubMed Web of Science ®Google Scholar
• JiaHLohrMJezequelSCysteine-rich and basic domain HIV-1 Tat peptides inhibit angiogenesis and induce endothelial cell apoptosisBiochem Biophys Res Commun2001283246947911327725
   PubMed Web of Science ®Google Scholar
• HuangMBKhanMGarcia-BarrioMPowellMBondVCApoptotic effects in primary human umbilical vein endothelial cell cultures caused by exposure to virion-associated and cell membrane-associated HIV-1 gp120J Acquir Immune Defic Syndr200127321322111464139
   PubMed Web of Science ®Google Scholar
• DhawanSPuriRKKumarADuplanHMassonJMAggarwalBBHuman immunodeficiency virus-1-tat protein induces the cell surface expression of endothelial leukocyte adhesion molecule-1, vascular cell adhesion molecule-1, and intercellular adhesion molecule-1 in human endothelial cellsBlood1997904153515449269771
   PubMed Web of Science ®Google Scholar
• RenZYaoQChenCHIV-1 envelope glycoprotein 120 increases intercellular adhesion molecule-1 expression by human endothelial cellsLab Invest200282324525511896203
   PubMed Web of Science ®Google Scholar
• SandlerNGSeretiICan early therapy reduce inflammation?Curr Opin HIV AIDS201491727924247669
   PubMed Web of Science ®Google Scholar
• LiovatASRey-CuilléMALécurouxCAcute plasma biomarkers of T cell activation set-point levels and of disease progression in HIV-1 infectionPLoS One2012710e4614323056251
   PubMed Web of Science ®Google Scholar
• BurdoTHSoulasCOrzechowskiKIncreased monocyte turnover from bone marrow correlates with severity of SIV encephalitis and CD163 levels in plasmaPLoS Pathog201064e100084220419144
   PubMed Web of Science ®Google Scholar
• HearpsACMaisaAChengWJHIV infection induces age-related changes to monocytes and innate immune activation in young men that persist despite combination antiretroviral therapyAIDS201226784385322313961
   PubMed Web of Science ®Google Scholar
• MartinGEGouillouMHearpsACAge-associated changes in monocyte and innate immune activation markers occur more rapidly in HIV infected womenPLoS One201381e5527923365694
   PubMed Web of Science ®Google Scholar
• ArmahKAMcGinnisKBakerJHIV status, burden of comorbid disease, and biomarkers of inflammation, altered coagulation, and monocyte activationClin Infect Dis201255112613622534147
   PubMed Web of Science ®Google Scholar
• CroweSMWesthorpeCLMukhamedovaNJaworowskiASviridovDBukrinskyMThe macrophage: the intersection between HIV infection and atherosclerosisJ Leukoc Biol201087458959819952353
   PubMed Web of Science ®Google Scholar
• MujawarZRoseHMorrowMPHuman immunodeficiency virus impairs reverse cholesterol transport from macrophagesPLoS Biol2006411e36517076584
   PubMed Web of Science ®Google Scholar
• FunderburgNTMarkers of coagulation and inflammation often remain elevated in ART-treated HIV-infected patientsCurr Opin HIV AIDS201491808624275673
   PubMed Web of Science ®Google Scholar
• AukrustPLunaLUelandTImpaired base excision repair and accumulation of oxidative base lesions in CD4+ T cells of HIV-infected patientsBlood2005105124730473515705786
   PubMed Web of Science ®Google Scholar
• GrunfeldCPangMDoerrlerWLipids, lipoproteins, triglyceride clearance, and cytokines in human immunodeficiency virus infection and the acquired immunodeficiency syndromeJ Clin Endocrinol Metab1992745104510521373735
   PubMed Web of Science ®Google Scholar
• RoseHHoyJWoolleyIHIV infection and high density lipoprotein metabolismAtherosclerosis20081991798618054941
   PubMed Web of Science ®Google Scholar
• OhJHegeleRAHIV-associated dyslipidaemia: pathogenesis and treatmentLancet Infect Dis200771278779618045561
   PubMed Web of Science ®Google Scholar
• NorataGDPirilloACatapanoALHDLs, immunity, and atherosclerosisCurr Opin Lipidol201122541041621881500
   PubMed Web of Science ®Google Scholar
• D’AscenzoFCerratoEAppletonDPercutaneous coronary intervention and surgical revascularization in HIV Database (PHD) Study InvestigatorsPrognostic indicators for recurrent thrombotic events in HIV-infected patients with acute coronary syndromes: use of registry data from 12 sites in Europe, South Africa and the United StatesThromb Res2014134355856425064035
   PubMed Web of Science ®Google Scholar
• MatetzkySDomingoMKarSAcute myocardial infarction in human immunodeficiency virus-infected patientsArch Intern Med2003163445746012588205
   PubMedGoogle Scholar
• SegevACantorWJStraussBHOutcome of percutaneous coronary intervention in HIV-infected patientsCatheter Cardiovasc Interv200668687988117086530
   PubMed Web of Science ®Google Scholar
• BoccaraFTeigerECohenAPercutaneous coronary intervention in HIV infected patients: immediate results and long term prognosisHeart200692454354416537777
   PubMed Web of Science ®Google Scholar
• BadrSMinhaSKitabataHSafety and long-term outcomes after percutaneous coronary intervention in patients with human immunodeficiency virusCatheter Cardiovasc Interv Epub2282014
   Google Scholar
• SavèsMChêneGDucimetièrePFrench WHO MONICA Project and the APROCO (ANRS EP11) Study GroupRisk factors for coronary heart disease in patients treated for human immunodeficiency virus infection compared with the general populationClin Infect Dis200337229229812856222
   PubMed Web of Science ®Google Scholar
• BrownTTColeSRLiXAntiretroviral therapy and the prevalence and incidence of diabetes mellitus in the multicenter AIDS cohort studyArch Intern Med2005165101179118415911733
   PubMedGoogle Scholar
• Friis-MøllerNWeberRReissPDAD study groupCardiovascular disease risk factors in HIV patients – association with antiretroviral therapy. Results from the DAD studyAIDS20031781179119312819520
   PubMed Web of Science ®Google Scholar
• SmithCJLevyISabinCAKayaEJohnsonMALipmanMCCardiovascular disease risk factors and antiretroviral therapy in an HIV-positive UK populationHIV Med200452889215012647
   PubMed Web of Science ®Google Scholar
• SantosJPalaciosRGonzálezMRuizJMárquezMAtherogenic lipid profile and cardiovascular risk factors in HIV-infected patients (Nétar Study)Int J STD AIDS2005161067768016212715
   PubMed Web of Science ®Google Scholar
• GlassTRUngsedhapandCWolbersMSwiss HIV Cohort StudyPrevalence of risk factors for cardiovascular disease in HIV-infected patients over time: the Swiss HIV Cohort StudyHIV Med20067640441016903986
   PubMed Web of Science ®Google Scholar
• KaplanRCKingsleyLASharrettARTen-year predicted coronary heart disease risk in HIV-infected men and womenClin Infect Dis20074581074108117879928
   PubMed Web of Science ®Google Scholar
• MasiáMPérez-CachafeiroSLeyesMGrupo de estudio de riesgo cardiovascular de CoRISCardiovascular risk in human immunodeficiency virus-infected patients in Spain. CoRIS cohort, 2011Enferm Infecc Microbiol Clin2012309517527 Spanish22551653
   PubMed Web of Science ®Google Scholar
• JoyTKeoghHMHadiganCDietary fat intake and relationship to serum lipid levels in HIV-infected patients with metabolic abnormalities in the HAART eraAIDS200721121591160017630554
   PubMed Web of Science ®Google Scholar
• MondyKOvertonETGrubbJMetabolic syndrome in HIV-infected patients from an urban, midwestern US outpatient populationClin Infect Dis200744572673417278068
   PubMed Web of Science ®Google Scholar
• PalaciosRSantosJGonzálezMRuizJMárquezMIncidence and prevalence of the metabolic syndrome in a cohort of naive HIV-infected patients: prospective analysis at 48 weeks of highly active antiretroviral therapyInt J STD AIDS200718318418717362552
   PubMed Web of Science ®Google Scholar
• DillonDGGurdasaniDRihaJAfrican Partnership for Chronic Disease Research (APCDR)Association of HIV and ART with cardiometabolic traits in sub-Saharan Africa: a systematic review and meta-analysisInt J Epidemiol20134261754177124415610
   PubMed Web of Science ®Google Scholar
• SchillaciGDe SocioGVPucciGAortic stiffness in untreated adult patients with human immunodeficiency virus infectionHypertension200852230831318559718
   PubMed Web of Science ®Google Scholar
• LekakisJIkonomidisIPaliosJAssociation of highly active antiretroviral therapy with increased arterial stiffness in patients infected with human immunodeficiency virusAm J Hypertens200922882883419556973
   PubMed Web of Science ®Google Scholar
• EcheverríaPBonjochAMoltóJPulse wave velocity as index of arterial stiffness in HIV-infected patients compared with a healthy populationJ Acquir Immune Defic Syndr2014651505623982659
   PubMed Web of Science ®Google Scholar
• AdinolfLERestivoLZampinoRChronic HCV infection is a risk of atherosclerosis. Role of HCV and HCV-related steatosisAtherosclerosis2012221249650222385985
   PubMed Web of Science ®Google Scholar
• IshizakaNIshizakaYTakahashiEAssociation between hepatitis C virus seropositivity, carotid-artery plaque, and intima-media thickeningLancet2002359930113313511809259
   PubMed Web of Science ®Google Scholar
• AlyanOKacmazFOzdemirOHepatitis C infection is associated with increased coronary artery atherosclerosis defined by modified Reardon severity score systemCirc J200872121960196518957787
   PubMed Web of Science ®Google Scholar
• VassalleCMasiniSBianchiFZucchelliGCEvidence for association between hepatitis C virus seropositivity and coronary artery diseaseHeart200490556556615084562
   PubMed Web of Science ®Google Scholar
• LeeMHYangHIWangCHHepatitis C virus infection and increased risk of cerebrovascular diseaseStroke201041122894290020966408
   PubMed Web of Science ®Google Scholar
• YounossiZMStepanovaMNaderFYounossiZElsheikhEAssociations of chronic hepatitis C with metabolic and cardiac outcomesAliment Pharmacol Ther201337664765223384408
   PubMed Web of Science ®Google Scholar
• HsuYHMuoCHLiuCYHepatitis C virus infection increases the risk of Developing peripheral arterial disease: a 9-year population-based cohort studyJ Hepatol Epub9252014
   Google Scholar
• SosnerPWangermezMChagneau-DerrodeCLe MoalGSilvainCAtherosclerosis risk in HIV-infected patients: the influence of hepatitis C virus co-infectionAtherosclerosis2012222127427722417840
   PubMed Web of Science ®Google Scholar
• BedimoRWestfallAOMugaveroMDrechslerHKhannaNSaagMHepatitis C virus coinfection and the risk of cardiovascular disease among HIV-infected patientsHIV Med201011746246820163481
   PubMed Web of Science ®Google Scholar
• GillisJSmiejaMCesconAOHTN Cohort Study GroupRisk of cardiovascular disease associated with HCV and HBV coinfection among antiretroviral-treated HIV-infected individualsAntivir Ther201419330931724429380
   PubMed Web of Science ®Google Scholar
• SutherlandMRRaynorCMLeenknegtHWrightJFPryzdialELCoagulation initiated on herpesvirusesProc Natl Acad Sci U S A1997942513510135149391056
   PubMed Web of Science ®Google Scholar
• SunYPeiWWuYJingZZhangJWangGHerpes simplex virus type 2 infection is a risk factor for hypertensionHypertens Res200427854154415492472
   PubMed Web of Science ®Google Scholar
• Espinola-KleinCRupprechtHJBlankenbergSAtheroGene InvestigatorsImpact of infectious burden on extent and long-term prognosis of atherosclerosisCirculation20021051152111772870
   PubMed Web of Science ®Google Scholar
• HsuePYHuntPWSinclairEIncreased carotid intima-media thickness in HIV patients is associated with increased cytomegalovirus-specific T-cell responsesAIDS200620182275228317117013
   PubMed Web of Science ®Google Scholar
• ParrinelloCMSinclairELandayALCytomegalovirus immunoglobulin G antibody is associated with subclinical carotid artery disease among HIV-infected womenJ Infect Dis2012205121788179622492856
   PubMed Web of Science ®Google Scholar
• HechterRCBudoffMHodisHNHerpes simplex virus type 2 (HSV-2) as a coronary atherosclerosis risk factor in HIV-infected men: multicenter AIDS cohort studyAtherosclerosis2012223243343622472456
   PubMed Web of Science ®Google Scholar
• IslamFMWuJJanssonJWilsonDPRelative risk of renal disease among people living with HIV: a systematic review and meta-analysisBMC Public Health20121223422439731
   PubMed Web of Science ®Google Scholar
• MaggiPBartolozziDBonfantiPRenal complications in HIV disease: between present and futureAIDS Rev2012141375322297503
   PubMed Web of Science ®Google Scholar
• KalayjianRCFranceschiniNGuptaSKSuppression of HIV-1 replication by antiretroviral therapy improves renal function in persons with low CD4 cell counts and chronic kidney diseaseAIDS200822448148718301060
   PubMed Web of Science ®Google Scholar
• ChoiAIShlipakMGHuntPWMartinJNDeeksSGHIV-infected persons continue to lose kidney function despite successful antiretro-viral therapyAIDS200923162143214919684507
   PubMed Web of Science ®Google Scholar
• KalayjianRCLauBMechekanoRNRisk factors for chronic kidney disease in a large cohort of HIV-1 infected individuals initiating antiretroviral therapy in routine careAIDS201226151907191522824630
   PubMed Web of Science ®Google Scholar
• NeuhausJJacobsDRBakerJVMarkers of inflammation, coagulation, and renal function are elevated in adults with HIV infectionJ Infect Dis2010201121788179520446848
   PubMed Web of Science ®Google Scholar
• CalzaLPocaterraDPavoniMPlasma levels of VCAM-1, ICAM-1, E-Selectin, and P-Selectin in 99 HIV-positive patients versus 51 HIV-negative healthy controlsJ Acquir Immune Defic Syndr200950443043219322038
   PubMed Web of Science ®Google Scholar
• MelendezMMMcNurlanMAMynarcikDCKhanSGelatoMCEndothelial adhesion molecules are associated with inflammation in subjects with HIV diseaseClin Infect Dis200846577578018225982
   PubMed Web of Science ®Google Scholar
• HilemanCOCarmanTLLongeneckerCTRate and predictors of carotid artery intima media thickness progression in antiretroviral-naive HIV-infected and uninfected adults: a 48-week matched prospective cohort studyAntivir Ther201318792192923756436
   PubMed Web of Science ®Google Scholar
• KurzKTeerlinkTSarclettiMWeissGZangerleRFuchsDPlasma concentrations of the cardiovascular risk factor asymmetric dimethylarginine (ADMA) are increased in patients with HIV-1 infection and correlate with immune activation markersPharmacol Res200960650851419651212
   PubMed Web of Science ®Google Scholar
• TriantVAMeigsJBGrinspoonSKAssociation of C-reactive protein and HIV infection with acute myocardial infarctionJ Acquir Immune Defic Syndr200951326827319387353
   PubMed Web of Science ®Google Scholar
• KullerLHTracyRBellosoWINSIGHT SMART Study GroupInflammatory and coagulation biomarkers and mortality in patients with HIV infectionPLoS Med2008510e20318942885
   PubMed Web of Science ®Google Scholar
• DuprezDANeuhausJKullerLHINSIGHT SMART Study GroupInflammation, coagulation and cardiovascular disease in HIV-infected individualsPLoS One201279e4445422970224
   PubMed Web of Science ®Google Scholar
• NordellADMcKennaMBorgesÁHDuprezDNeuhausJNeatonJDINSIGHT SMART, ESPRIT Study GroupsSILCAAT Scientific Committee.Severity of cardiovascular disease outcomes among patients with HIV is related to markers of inflammation and coagulationJ Am Heart Assoc201433e00084424870935
   PubMed Web of Science ®Google Scholar
• TenorioARZhengYBoschRJSoluble markers of inflammation and coagulation but not T-cell activation predict non-AIDS-defining morbid events during suppressive antiretroviral treatmentJ Infect Dis201421081248125924795473
   PubMed Web of Science ®Google Scholar
• LongeneckerCTFunderburgNTJiangYMarkers of inflammation and CD8 T-cell activation, but not monocyte activation, are associated with subclinical carotid artery disease in HIV-infected individualsHIV Med201314638539023332012
   PubMed Web of Science ®Google Scholar
• RossACRizkNO’RiordanMARelationship between inflammatory markers, endothelial activation markers, and carotid intima-media thickness in HIV-infected patients receiving antiretroviral therapyClin Infect Dis20094971119112719712036
   PubMed Web of Science ®Google Scholar
• JangJJBerkheimerSBMerchantMKrishnaswamiAAsymmetric dimethylarginine and coronary artery calcium scores are increased in patients infected with human immunodeficiency virusAtherosclerosis2011217251451721549379
   PubMed Web of Science ®Google Scholar
• BurdoTHLentzMRAutissierPSoluble CD163 made by monocyte/macrophages is a novel marker of HIV activity in early and chronic infection prior to and after anti-retroviral therapyJ Infect Dis2011204115416321628670
   PubMed Web of Science ®Google Scholar
• BeltránLMMuñoz HernándezRde Pablo BernalRSReduced sTWEAK and increased sCD163 levels in HIV-infected patients: modulation by antiretroviral treatment, HIV replication and HCV co-infectionPLoS One201493e9054124594990
   PubMed Web of Science ®Google Scholar
• BurdoTHLoJAbbaraSSoluble CD163, a novel marker of activated macrophages, is elevated and associated with noncalcified coronary plaque in HIV-infected patientsJ Infect Dis201120481227123621917896
   PubMed Web of Science ®Google Scholar
• FitchKVSrinivasaSAbbaraSNoncalcified coronary atherosclerotic plaque and immune activation in HIV-infected womenJ Infect Dis2013208111737174624041790
   PubMed Web of Science ®Google Scholar
• SubramanianSTawakolABurdoTHArterial inflammation in patients with HIVJAMA2012308437938622820791
   PubMed Web of Science ®Google Scholar
• LongeneckerCTJiangYOrringerCESoluble CD14 is independently associated with coronary calcification and extent of subclinical vascular disease in treated HIV infectionAIDS201428796997724691204
   PubMed Web of Science ®Google Scholar
• BakerJVHullsiekKHSinghACDC SUN Study InvestigatorsImmunologic predictors of coronary artery calcium progression in a contemporary HIV cohortAIDS201428683184024370480
   PubMed Web of Science ®Google Scholar
• KristoffersenUSKofoedKKronborgGGigerAKKjaerALebechAMReduction in circulating markers of endothelial dysfunction in HIV-infected patients during antiretroviral therapyHIV Med2009102798719200170
   PubMed Web of Science ®Google Scholar
• McComseyGAKitchDDaarESInflammation markers after randomization to abacavir/lamivudine or tenofovir/emtricitabine with efavirenz or atazanavir/ritonavirAIDS201226111371138522546988
   PubMed Web of Science ®Google Scholar
• CalmyAGayet-AgeronAMontecuccoFSTACCATO Study GroupHIV increases markers of cardiovascular risk: results from a randomized, treatment interruption trialAIDS200923892993919425222
   PubMed Web of Science ®Google Scholar
• WolfKTsakirisDAWeberRErbPBattegayMSwiss HIV Cohort StudyAntiretroviral therapy reduces markers of endothelial and coagulation activation in patients infected with human immunodeficiency virus type 1J Infect Dis2002185445646211865397
   PubMed Web of Science ®Google Scholar
• KurzKTeerlinkTSarclettiMWeissGZangerleRFuchsDAsymmetric dimethylarginine concentrations decrease in patients with HIV infection under antiretroviral therapyAntivir Ther20121761021102722892398
   PubMed Web of Science ®Google Scholar
• BakerJVNeuhausJDuprezDINSIGHT SMART Study GroupHIV replication, inflammation, and the effect of starting antiretroviral therapy on plasma asymmetric dimethylarginine, a novel marker of endothelial dysfunctionJ Acquir Immune Defic Syndr201260212813422421746
   PubMed Web of Science ®Google Scholar
• JaworowskiAElleryPMaslinCLNormal CD16 expression and phagocytosis of Mycobacterium avium complex by monocytes from a current cohort of HIV-1-infected patientsJ Infect Dis2006193569369716453265
   PubMed Web of Science ®Google Scholar
• KamatAMisraVCassolEA plasma biomarker signature of immune activation in HIV patients on antiretroviral therapyPLoS One201272e3088122363505
   PubMed Web of Science ®Google Scholar
• MalherbeGSteelHCCassolSCirculating biomarkers of immune activation distinguish viral suppression from nonsuppression in HAART-treated patients with advanced HIV-1 subtype C infectionMediators Inflamm2014201419841324808634
   PubMed Web of Science ®Google Scholar
• HatanoHYuklSAFerreALProspective antiretroviral treatment of asymptomatic, HIV-1 infected controllersPLoS Pathog2013910e100369124130489
   PubMed Web of Science ®Google Scholar
• HsuePYHuntPWSchnellARole of viral replication, antiretroviral therapy, and immunodeficiency in HIV-associated atherosclerosisAIDS20092391059106719390417
   PubMed Web of Science ®Google Scholar
• PereyraFLoJTriantVAIncreased coronary atherosclerosis and immune activation in HIV-1 elite controllersAIDS201226182409241223032411
   PubMed Web of Science ®Google Scholar
• HoJEScherzerRHechtFMThe association of CD4+ T-cell counts and cardiovascular risk in treated HIV diseaseAIDS20122691115112022382147
   PubMed Web of Science ®Google Scholar
• van LelyveldSFGrasLKesselringAATHENA national observational cohort studyLong-term complications in patients with poor immunological recovery despite virological successful HAART in Dutch ATHENA cohortAIDS201226446547422112603
   PubMed Web of Science ®Google Scholar
• GrantPMKitchDMcComseyGALow baseline CD4+ count is associated with greater bone mineral density loss after antiretroviral therapy initiationClin Infect Dis201357101483148823943825
   PubMed Web of Science ®Google Scholar
• ChevalierMFPetitjeanGDunyach-RémyCThe Th17/Treg ratio, IL-1RA and sCD14 levels in primary HIV infection predict the T-cell activation set point in the absence of systemic microbial translocationPLoS Pathog201396e100345323818854
   PubMed Web of Science ®Google Scholar
• VinikoorMJCopeAGayCLAntiretroviral therapy initiated during acute HIV infection fails to prevent persistent T-cell activationJ Acquir Immune Defic Syndr201362550550823314410
   PubMed Web of Science ®Google Scholar
• JainVHartogensisWBacchettiPAntiretroviral therapy initiated within 6 months of HIV infection is associated with lower T-cell activation and smaller HIV reservoir sizeJ Infect Dis201320881202121123852127
   PubMed Web of Science ®Google Scholar
• WilkinTJLalamaCMMcKinnonJA pilot trial of adding maraviroc to suppressive antiretroviral therapy for suboptimal CD4+ T-cell recovery despite sustained virologic suppression: ACTG A5256J Infect Dis2012206453454222740718
   PubMed Web of Science ®Google Scholar
• HuntPWShulmanNSHayesTLThe immunologic effects of maraviroc intensification in treated HIV-infected individuals with incomplete CD4+ T-cell recovery: a randomized trialBlood2013121234635464623589670
   PubMed Web of Science ®Google Scholar
• MassanellaMNegredoEPuigJRaltegravir intensification shows differing effects on CD8 and CD4 T cells in HIV-infected HAART-suppressed individuals with poor CD4 T-cell recoveryAIDS201226182285229323018435
   PubMed Web of Science ®Google Scholar
• HatanoHScherzerRWuYA randomized controlled trial assessing the effects of raltegravir intensification on endothelial function in treated HIV infectionJ Acquir Immune Defic Syndr201261331732522918156
   PubMed Web of Science ®Google Scholar
• HatanoHStrainMCScherzerRIncrease in 2-long terminal repeat circles and decrease in D-dimer after raltegravir intensification in patients with treated HIV infection: a randomized, placebo-controlled trialJ Infect Dis201320891436144223975885
   PubMed Web of Science ®Google Scholar
• SilvaEFCharreauIGourmelBANRS 138 EASIER Study GroupDecreases in inflammatory and coagulation biomarkers levels in HIV-infected patients switching from enfuvirtide to raltegravir: ANRS 138 substudyJ Infect Dis2013208689289723801606
   PubMed Web of Science ®Google Scholar
• MartínezED’AlbuquerquePMLlibreJMSPIRAL Trial GroupChanges in cardiovascular biomarkers in HIV-infected patients switching from ritonavir-boosted protease inhibitors to raltegravirAIDS201226182315232623018438
   PubMed Web of Science ®Google Scholar
• MasiáMMartínezEPadillaSGatellJMGutiérrezFEndothelial function in HIV-infected patients switching from a boosted protease inhibitor-based regimen to raltegravir: a substudy of the SPIRAL studyJ Antimicrob Chemother201368240941323075691
   PubMed Web of Science ®Google Scholar
• KlattNRFunderburgNTBrenchleyJMMicrobial translocation, immune activation, and HIV diseaseTrends Microbiol201321161323062765
   PubMed Web of Science ®Google Scholar
• BrenchleyJMPriceDASchackerTWMicrobial translocation is a cause of systemic immune activation in chronic HIV infectionNat Med200612121365137117115046
   PubMed Web of Science ®Google Scholar
• WilsonEMSeretiIImmune restoration after antiretroviral therapy: the pitfalls of hasty or incomplete repairsImmunol Rev2013254134335423772630
   PubMedGoogle Scholar
• MehandruSPolesMATenner-RaczKPrimary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tractJ Exp Med2004200676177015365095
   PubMed Web of Science ®Google Scholar
• MavignerMCazabatMDuboisMAltered CD4+ T cell homing to the gut impairs mucosal immune reconstitution in treated HIV-infected individualsJ Clin Invest20121221626922156200
   PubMed Web of Science ®Google Scholar
• LegeinBTemmermanLBiessenEALutgensEInflammation and immune system interactions in atherosclerosisCell Mol Life Sci2013702038476923430000
   PubMed Web of Science ®Google Scholar
• FunderburgNTJiangYDebanneSMRosuvastatin treatment reduces markers of monocyte activation in HIV-infected subjects on antiretroviral therapyClin Infect Dis201458458859524253250
   PubMed Web of Science ®Google Scholar
• EckardARJiangYDebanneSMFunderburgNTMcComseyGAEffect of 24 weeks of statin therapy on systemic and vascular inflammation in HIV-infected subjects receiving antiretroviral therapyJ Infect Dis201420981156116424415784
   PubMed Web of Science ®Google Scholar
• RidkerPMCushmanMStampferMJTracyRPHennekensCHInflammation, aspirin, and the risk of cardiovascular disease in apparently healthy menN Engl J Med1997336149739799077376
   PubMed Web of Science ®Google Scholar
• RidkerPMHennekensCHBuringJERifaiNC-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in womenN Engl J Med20003421283684310733371
   PubMed Web of Science ®Google Scholar
• RidkerPMBuringJECookNRRifaiNC-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14 719 initially healthy American womenCirculation2003107339139712551861
   PubMed Web of Science ®Google Scholar
• BallantyneCMHoogeveenRCBangHLipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident ischemic stroke in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) studyArch Intern Med2005165212479248416314544
   PubMedGoogle Scholar
• FordESGreenwaldJHRichtermanAGTraditional risk factors and D-dimer predict incident cardiovascular disease events in chronic HIV infectionAIDS201024101509151720505494
   PubMed Web of Science ®Google Scholar
• CesariMPenninxBWNewmanABInflammatory markers and cardiovascular disease (The Health, Aging and Body Composition [Health ABC] Study)Am J Cardiol200392552252812943870
   PubMed Web of Science ®Google Scholar
• FolsomARChamblessLEBallantyneCMAn assessment of incremental coronary risk prediction using C-reactive protein and other novel risk markers: the atherosclerosis risk in communities studyArch Intern Med2006166131368137316832001
   PubMed Web of Science ®Google Scholar
• TzoulakiIMurrayGDLeeAJRumleyALoweGDFowkesFGRelative value of inflammatory, hemostatic, and rheological factors for incident myocardial infarction and stroke: the Edinburgh Artery StudyCirculation2007115162119212717404162
   PubMed Web of Science ®Google Scholar
• DaneshJKaptogeSMannAGLong-term interleukin-6 levels and subsequent risk of coronary heart disease: two new prospective studies and a systematic reviewPLoS Med200854e7818399716
   PubMed Web of Science ®Google Scholar
• TakeiYDi TullioMRHommaSSoluble tumor necrosis factor receptor 1 level is associated with left ventricular hypertrophy: the northern Manhattan studyAm J Hypertens200922776376919390513
   PubMed Web of Science ®Google Scholar
• ValgimigliMCeconiCMalaguttiPTumor necrosis factor-alpha receptor 1 is a major predictor of mortality and new-onset heart failure in patients with acute myocardial infarction: the Cytokine-Activation and Long-Term Prognosis in Myocardial Infarction (C-ALPHA) studyCirculation2005111786387015699251
   PubMed Web of Science ®Google Scholar
• UelandTKjekshusJFrølandSSPlasma levels of soluble tumor necrosis factor receptor type I during the acute phase following complicated myocardial infarction predicts survival in high-risk patientsJ Am Coll Cardiol200546112018202116325035
   PubMed Web of Science ®Google Scholar
• NilssonLSzymanowskiASwahnEJonassonLSoluble TNF receptors are associated with infarct size and ventricular dysfunction in ST-elevation myocardial infarctionPLoS One201382e5547723405158
   PubMed Web of Science ®Google Scholar
• MorenoJAMuñoz-GarcíaBMartín-VenturaJLThe CD163-expressing macrophages recognize and internalize TWEAK: potential consequences in atherosclerosisAtherosclerosis2009207110311019473660
   PubMed Web of Science ®Google Scholar
• AristoteliLPMøllerHJBaileyBMoestrupSKKritharidesLThe monocytic lineage specific soluble CD163 is a plasma marker of coronary atherosclerosisAtherosclerosis2006184234234715979079
   PubMed Web of Science ®Google Scholar
• MorenoJADejouvencelTLabreucheJPeripheral artery disease is associated with a high CD163/TWEAK plasma ratioArterioscler Thromb Vasc Biol20103061253126220299688
   PubMed Web of Science ®Google Scholar
• KnudsenAMøllerHJKatzensteinTLSoluble CD163 does not predict first-time myocardial infarction in patients infected with human immunodeficiency virus: a nested case-control studyBMC Infect Dis20131323023692821
   PubMed Web of Science ®Google Scholar
• ReinerAPLangeEMJennyNSSoluble CD14: genomewide association analysis and relationship to cardiovascular risk and mortality in older adultsArterioscler Thromb Vasc Biol201333115816423162014
   PubMed Web of Science ®Google Scholar
• KelesidisTKendallMAYangOOHodisHNCurrierJSBiomarkers of microbial translocation and macrophage activation: association with progression of subclinical atherosclerosis in HIV-1 infectionJ Infect Dis2012206101558156723066162
   PubMed Web of Science ®Google Scholar
• RogacevKSSeilerSZawadaAMCD14++CD16+ monocytes and cardiovascular outcome in patients with chronic kidney diseaseEur Heart J2011321849220943670
   PubMed Web of Science ®Google Scholar
• RogacevKSCremersBZawadaAMCD14++CD16+ monocytes independently predict cardiovascular events: a cohort study of 951 patients referred for elective coronary angiographyJ Am Coll Cardiol201260161512152022999728
   PubMed Web of Science ®Google Scholar
• HeineGHUlrichCSeibertECD14(++)CD16+ monocytes but not total monocyte numbers predict cardiovascular events in dialysis patientsKidney Int200873562262918160960
   PubMed Web of Science ®Google Scholar
• JaipersadASShantsilaALipGYShantsilaEExpression of monocyte subsets and angiogenic markers in relation to carotid plaque neovascularization in patients with pre-existing coronary artery disease and carotid stenosisAnn Med20141119
   Google Scholar
• BergKELjungcrantzIAnderssonLElevated CD14++CD16-monocytes predict cardiovascular eventsCirc Cardiovasc Genet20125112213122238190
   PubMedGoogle Scholar
• BarbourJDJalbertECChowDCReduced CD14 expression on classical monocytes and vascular endothelial adhesion markers independently associate with carotid artery intima media thickness in chronically HIV-1 infected adults on virologically suppressive anti-retroviral therapyAtherosclerosis20142321525824401216
   PubMed Web of Science ®Google Scholar
• HwangSJBallantyneCMSharrettARCirculating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) studyCirculation19979612421942259416885
   PubMed Web of Science ®Google Scholar
• BlankenbergSRupprechtHJBickelCCirculating cell adhesion molecules and death in patients with coronary artery diseaseCirculation2001104121336134211560847
   PubMed Web of Science ®Google Scholar
• HilemanCOLongeneckerCTCarmanTLMcComseyGAC-reactive protein predicts 96-week carotid intima media thickness progression in HIV-infected adults naive to antiretroviral therapyJ Acquir Immune Defic Syndr201465334034424220288
   PubMed Web of Science ®Google Scholar
• SchnabelRBlankenbergSLubosEAsymmetric dimethylarginine and the risk of cardiovascular events and death in patients with coronary artery disease: results from the AtheroGene StudyCirc Res2005975e53e5916100045
   PubMed Web of Science ®Google Scholar
• LeongTZylbersteinDGrahamISwedish-Irish-Norwegian CollaborationAsymmetric dimethylarginine independently predicts fatal and nonfatal myocardial infarction and stroke in women: 24-year follow-up of the population study of women in GothenburgArterioscler Thromb Vasc Biol200828596196718292394
   PubMed Web of Science ®Google Scholar
• ParikhRVScherzerRNittaEMIncreased levels of asymmetric dimethylarginine are associated with pulmonary arterial hypertension in HIV infectionAIDS201428451151924469026
   PubMed Web of Science ®Google Scholar
• Blanco-ColioLMMartín-VenturaJLMuñóz-GarcíaBIdentification of soluble tumor necrosis factor-like weak inducer of apoptosis (sTWEAK) as a possible biomarker of subclinical atherosclerosisArterioscler Thromb Vasc Biol200727491692217272745
   PubMed Web of Science ®Google Scholar
• Jelić-IvanovićZBujisićNSpasićSBogavac-StanojevićNSpasojević-KalimanovskaVKotur-StevuljevićJCirculating sTWEAK improves the prediction of coronary artery diseaseClin Biochem20094213–141381138619505454
   PubMed Web of Science ®Google Scholar
• YilmazMISonmezAOrtizASoluble TWEAK and PTX3 in nondialysis CKD patients: impact on endothelial dysfunction and cardiovascular outcomesClin J Am Soc Nephrol20116478579221330486
   PubMed Web of Science ®Google Scholar
• ChorianopoulosERosenbergMZugckCWolfJKatusHAFreyNDecreased soluble TWEAK levels predict an adverse prognosis in patients with chronic stable heart failureEur J Heart Fail200911111050105619875405
   PubMed Web of Science ®Google Scholar
• UrbonavicieneGMartin-VenturaJLLindholtJSImpact of soluble TWEAK and CD163/TWEAK ratio on long-term cardiovascular mortality in patients with peripheral arterial diseaseAtherosclerosis2011219289289921962403
   PubMed Web of Science ®Google Scholar